The use of probiotics administered either in a direct clinical sense or indirectly as a food additive
has grown greatly in recent years due to the new 'healthy living' trend. The global market for
probiotics was worth R186.2 billion in 2013, showing a growth of 4.3% compounded per annum
over a period of five years. Probiotics are however sensitive to different environmental factors
such as light, moisture and oxidation in addition to the stresses encountered during processing.
The shelf of probiotics in foodstuffs and pharmaceuticals are limited, which lead to increased
costs to the manufacturer in having to incorporate enough cultures to account for losses, or a
decreased benefit to the consumer in not receiving the required amount of cells needed for health
benefits to be actualized. Microencapsulation is a technique used to protect probiotic cells
against harsh conditions encountered both in the environment during storage and transport, and
in the human body after consumption. This leads to higher numbers of viable probiotic cells
being available to the consumer after consumption and decreased costs to the manufacturer as
less cells need to be added.
Current microencapsulation techniques are plagued with problems such as the inability to be
produced at an industrial scale, the use of toxic solvents which kill the probiotic cells and
contribute to pollution and the need for FDA approval of the pharmaceutical grade excipients
they use. A novel encapsulation technique using the Particles from a Gas Saturated Solution (PGSS)
system has been developed by the Council for Scientific and Industrial Research (CSIR), which
does not require organic solvents and uses carbon dioxide in a supercritical state to create
microcapsules.
There is very limited knowledge on the use of lipid based food grade excipients for use in
probiotic microencapsulation for food applications. The combination of these ideas could result
in a novel method of protecting sensitive food additives, in addition to creating a platform for
new techniques in the pharmaceutical and food industries.
Bifidobacteria were successfully encapsulated using the novel PGSS method. Two lipid based
excipients, Compritol E 472 ATO and Vegetal BM 297 ATO were tested to determine if they
could be used in the microencapsulation of bifidobacteria. Results showed that the temperature
needed to successfully liquefy the Compritol resulted in high losses of cells. It was decided to
continue the study with only Vegetal BM 297 ATO which resulted in much lower losses of
probiotic cells. The results demonstrated that the cells were successfully encapsulated inside
Vegetal BM 297 ATO microparticles. The particles contained high numbers of cells and the
process did not cause any morphological changes on the probiotic cells. The process was
optimized by changing the reaction formulation and mixing chamber parameters until an
encapsulation efficiency (EE) of 88% was attained. The Vegetal microparticles containing the
bifidobacteria were a very desirable size for use in the food industry. This was the first time the
use of a lipid based food grade excipient in microencapsulation of probiotics using a PGSS
procedure was demonstrated. This result leads to further testing of the Vegetal BM 297 ATO
microparticles containing bifidobacteria in in vitro gastrointestinal environments.
It was found that the Vegetal BM 297 ATO matrix provided a protective effect on the cells
during simulated gastrointestinal transit. There were more viable cultures in the sample
containing encapsulated cells after exposure to simulated gastric fluid (SGF) and subsequently
simulated intestinal fluid (SIF). The cells were released from the Vegetal BM 297 ATO matrix
over 7 hours after an initial decrease in numbers. The viable numbers of non-encapsulated cells
continuously decreased while the encapsulated cells continuously increased over time during
exposure. The microparticles were subsequently tested to see if they increased the shelf life of
bifidobacteria under different storage conditions. It was found that during refrigerated storage the
microparticles did not increase the shelf life of bifidobacteria, but that it had a slight protective
effect when stored at room temperature. / Dissertation (MSc)--University of Pretoria, 2014. / lk2014 / Microbiology and Plant Pathology / MSc / Unrestricted
| Identifer | oai:union.ndltd.org:netd.ac.za/oai:union.ndltd.org:up/oai:repository.up.ac.za:2263/43139 |
| Date | January 2014 |
| Creators | Labuschagne, Markus Christof |
| Contributors | Thantsha, Mapitsi Silvester, markuslabuschagne@gmail.com, Labuschagne, P.W. |
| Source Sets | South African National ETD Portal |
| Language | English |
| Detected Language | English |
| Type | Dissertation |
| Rights | © 2014 University of Pretoria. All rights reserved. The copyright in this work vests in the University of Pretoria. No part of this work may be reproduced or transmitted in any form or by any means, without the prior written permission of the University of Pretoria. |
Page generated in 0.0022 seconds